tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Justin Keywood, 1 are a BUY (100%).
Analyst Justin Keywood, currently employed at STIFEL,
Most recent stock forecast was given on MEDXF, Medexus Pharmaceuticals.
Analyst best performing recommendations are on MEDXF (MEDEXUS PHARMACEUTICALS).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
